What question did this study set out to answer?

To investigate how insurance changes affect the delivery and implementation of long-acting cabotegravir plus rilpivirine therapy.

April 6, 2026Open Access

Real-World Impact of Insurance Changes on Long-Acting Cabotegravir Plus Rilpivirine Delivery

Key Points

To investigate how insurance changes affect the delivery and implementation of long-acting cabotegravir plus rilpivirine therapy.
Examined a cohort in the United States
Analyzed the frequency of insurance changes
Assessed implications of those changes on injection delivery
Nearly half of patients experienced insurance changes
Insurance changes could lead to delayed injections
Potential disruptions in treatment adherence identified

Abstract

Abstract Long-acting injectable cabotegravir plus rilpivirine offers an alternative to daily oral antiretroviral therapy, but insurance-related barriers can disrupt implementation. We examined the frequency and impact of insurance changes in a United States cohort and found that nearly half of patients experienced insurance changes, which could lead to delayed injections.

Read Full Paperexternally

KI fragen

Bookmark

View Full Paper

Cite This Study

Davis et al. (Thu,) studied this question.

synapsesocial.com/papers/69d34e1e9c07852e0af97b43 https://doi.org/https://doi.org/10.1093/ofid/ofag211

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

KI fragen

Bookmark

View Full Paper